Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study is to assess transplant-related mortality (TRM) at one year after allogeneic hematopoietic stem cell transplantation (allo-HSCT) prepared by a \"reduced toxicity myeloablative\" conditioning regimen in young patients (children and adolescents) with hematologic malignancies.
Epistemonikos ID: ec4249ebbc44df878f02bb3190a8b28aa3a84a1a
First added on: May 10, 2024